We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$246M
AUM Growth
-$8.32M
Cap. Flow
+$6.35M
Cap. Flow %
2.58%
Top 10 Hldgs %
46.09%
Holding
106
New
14
Increased
20
Reduced
56
Closed
9

Top Buys

Rank Stock Value
1
CTNM
Contineum Therapeutics
CTNM
+$12.9M
2
CVS icon
CVS Health
CVS
+$2.44M
3
BNTX icon
BioNTech
BNTX
+$2.17M
4
EVH icon
Evolent Health
EVH
+$2.15M
5
SYK icon
Stryker
SYK
+$2.12M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$2.67M
2
PODD icon
Insulet
PODD
+$1.94M
3
EYPT icon
EyePoint Inc
EYPT
+$1.91M
4
ATEC icon
Alphatec Holdings
ATEC
+$1.88M
5
LLY icon
Eli Lilly
LLY
+$1.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$21.2M 8.62%
23,415
-2,250
-9% -$1.8M
LENZ
2
LENZ Therapeutics
LENZ
$162M
$18.7M 7.62%
1,084,404
+15,729
+1% +$275K
CTNM
3
Contineum Therapeutics
CTNM
$532M
$14.1M 5.73%
+800,887
New +$12.9M
UNH icon
4
UnitedHealth
UNH
$387B
$13.6M 5.52%
26,675
+3,500
+15% +$1.72M
MRK icon
5
Merck
MRK
$315B
$10.7M 4.35%
86,500
– –
JNJ icon
6
Johnson & Johnson
JNJ
$609B
$8.31M 3.38%
56,850
+9,000
+19% +$1.34M
ABBV icon
7
AbbVie
ABBV
$450B
$7.71M 3.13%
44,950
+9,750
+28% +$1.62M
ABT icon
8
Abbott
ABT
$175B
$6.88M 2.8%
66,248
-4,000
-6% -$424K
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.9B
$6.35M 2.58%
6,040
-1,035
-15% -$1M
TMO icon
10
Thermo Fisher Scientific
TMO
$198B
$5.81M 2.36%
10,515
+500
+5% +$286K
BSX icon
11
Boston Scientific
BSX
$65.4B
$5.5M 2.24%
71,476
-15,000
-17% -$1.1M
MLYS icon
12
Mineralys Therapeutics
MLYS
$2.39B
$5.13M 2.09%
438,748
-113,508
-21% -$1.43M
PFE icon
13
Pfizer
PFE
$143B
$5.08M 2.06%
181,400
-8,000
-4% -$220K
GILD icon
14
Gilead Sciences
GILD
$167B
$4.72M 1.92%
68,825
+30,120
+78% +$2.01M
MDT icon
15
Medtronic
MDT
$106B
$4.69M 1.9%
59,551
+21,500
+57% +$1.76M
AMGN icon
16
Amgen
AMGN
$198B
$4.59M 1.87%
14,700
-1,385
-9% -$407K
DHR icon
17
Danaher
DHR
$144B
$4.43M 1.8%
17,725
– –
SYK icon
18
Stryker
SYK
$123B
$4.37M 1.78%
12,850
+6,250
+95% +$2.12M
VRTX icon
19
Vertex Pharmaceuticals
VRTX
$123B
$4.05M 1.65%
8,650
+1,440
+20% +$625K
DXCM icon
20
DexCom
DXCM
$29.6B
$3.65M 1.48%
32,150
-250
-0.8% -$31.6K
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.4M 1.38%
41,260
-10,380
-20% -$864K
IQV icon
22
IQVIA
IQV
$34.4B
$3.3M 1.34%
15,600
+1,500
+11% +$341K
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$35.7B
$3.03M 1.23%
12,480
-5,980
-32% -$944K
ZBH icon
24
Zimmer Biomet
ZBH
$17.6B
$2.89M 1.18%
26,650
-3,100
-10% -$365K
ARGX icon
25
argenx
ARGX
$53.8B
$2.8M 1.14%
6,522
-2,785
-30% -$1.07M
1
2 3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sectoral Asset Management held 106 positions worth $246M, down 3.3% from $254M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sectoral Asset Management's Q2 2024 filing shows 14 new, 20 increased, 56 reduced and 9 closed positions. Its largest new stake was Contineum Therapeutics: 800,887 shares worth $14.1M. The largest sale was Centene, an estimated $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sectoral Asset Management's largest Q2 2024 buy was Contineum Therapeutics: 800,887 shares worth $14.1M.
  • Sectoral Asset Management added most to BioNTech in Q2 2024, an estimated $2.17M increase.
  • Sectoral Asset Management's biggest Q2 2024 reduction was Insulet, cutting an estimated $1.94M.
  • Sectoral Asset Management fully exited Centene in Q2 2024, selling an estimated $2.67M.
  • Sectoral Asset Management's ten largest holdings make up 46% of its $246M portfolio in Q2 2024.
  • Sectoral Asset Management opened 14 new positions and closed 9 in Q2 2024.
  • Sectoral Asset Management's portfolio value fell 3.3% quarter-over-quarter to $246M.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.